DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR
Background: Sofosbuvir (SOF) and daclatasvir (DCV) are usually prescribed in combination for the treatment of hepatitis C worldwide. Objectives: In the present study a novel, simple, rapid, and cost-effective reversed-phase high performance liquid chromatography (HPLC) method was developed, optimis...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Superior University Lahore, Pakistan
2024-03-01
|
| Series: | International Journal of Pharmacy & Integrated Health Sciences |
| Subjects: | |
| Online Access: | https://ijpihs.pk/index.php/IJPIHS/article/view/118 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849422201462194176 |
|---|---|
| author | Syed Hassan Murtaza Ahmed Umer Sohaib Ahmed Tassawer-e-Meran Sonam Anees Najam-ul-Hassan Khan Kishwar Sultana |
| author_facet | Syed Hassan Murtaza Ahmed Umer Sohaib Ahmed Tassawer-e-Meran Sonam Anees Najam-ul-Hassan Khan Kishwar Sultana |
| author_sort | Syed Hassan Murtaza |
| collection | DOAJ |
| description |
Background: Sofosbuvir (SOF) and daclatasvir (DCV) are usually prescribed in combination for the treatment of hepatitis C worldwide. Objectives: In the present study a novel, simple, rapid, and cost-effective reversed-phase high performance liquid chromatography (HPLC) method was developed, optimised, and validated for simultaneous analysis of sofosbuvir and daclatasvir in human plasma as well as in solid dosage forms. Methodology: The chromatographic analyses were carried out using Shimadzu HPLC gradient system (LC20), while the other HPLC system used for the peak purity and repeated validation studies was Agilent 1260 Infinity fitted with diode array detector. The column used was C18 (150 × 4.6 mm; 5 µm), from Agela Technologies. The mobile phase consisted of acetonitrile and 0.02 M potassium Hexafluorophosphate buffer (42:58, v/v) at pH 2.7, pumped at the rate of 1.3 mL min−1. The limit of detection and limit of quantification were determined using dilution method (RSD/m formula). Results: SOF and DCV combination therapy is significant for the treatment of hepatitis C. Development of this RP-HPLC method for the simultaneous determination and quantification of SOF and DCV is a part of an extensive project of novel formulation development (fixed dose combination tablets of SOF and DCV). This method is successfully applied for raw materials as well as in combination tablets. This method may also be applied for the quantification of sofosbuvir and daclatasvir in blood samples of patients taking these two antivirals for hepatitis C treatment. Conclusion: The optimized method was successfully applied for the determination of sofosbuvir and daclatasvir in single run without any interference. Hence, the developed method is quite appropriate for the simultaneous determination of SOF and DCV in solid dosage form as well as in human plasma for clinical research studies.
|
| format | Article |
| id | doaj-art-2f33afa5ea254019b0f18bd10f95db88 |
| institution | Kabale University |
| issn | 2958-1656 2789-2840 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | Superior University Lahore, Pakistan |
| record_format | Article |
| series | International Journal of Pharmacy & Integrated Health Sciences |
| spelling | doaj-art-2f33afa5ea254019b0f18bd10f95db882025-08-20T03:31:11ZengSuperior University Lahore, PakistanInternational Journal of Pharmacy & Integrated Health Sciences2958-16562789-28402024-03-015110.56536/ijpihs.v5i1.118DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIRSyed Hassan Murtaza0Ahmed Umer Sohaib Ahmed1Tassawer-e-Meran2Sonam Anees3Najam-ul-Hassan Khan4Kishwar Sultana5Faculty of Pharmacy, The University of Lahore, Lahore PakistanFaculty of Pharmacy, The University of Lahore, Lahore PakistanYashfeen College of Pharmacy, Lahore, PakistanUniversity College of Pharmacy, University of the Punjab, Lahore, PakistanFaculty of Pharmacy, The University of Lahore, Lahore PakistanFaculty of Pharmacy, The University of Lahore, Lahore Pakistan Background: Sofosbuvir (SOF) and daclatasvir (DCV) are usually prescribed in combination for the treatment of hepatitis C worldwide. Objectives: In the present study a novel, simple, rapid, and cost-effective reversed-phase high performance liquid chromatography (HPLC) method was developed, optimised, and validated for simultaneous analysis of sofosbuvir and daclatasvir in human plasma as well as in solid dosage forms. Methodology: The chromatographic analyses were carried out using Shimadzu HPLC gradient system (LC20), while the other HPLC system used for the peak purity and repeated validation studies was Agilent 1260 Infinity fitted with diode array detector. The column used was C18 (150 × 4.6 mm; 5 µm), from Agela Technologies. The mobile phase consisted of acetonitrile and 0.02 M potassium Hexafluorophosphate buffer (42:58, v/v) at pH 2.7, pumped at the rate of 1.3 mL min−1. The limit of detection and limit of quantification were determined using dilution method (RSD/m formula). Results: SOF and DCV combination therapy is significant for the treatment of hepatitis C. Development of this RP-HPLC method for the simultaneous determination and quantification of SOF and DCV is a part of an extensive project of novel formulation development (fixed dose combination tablets of SOF and DCV). This method is successfully applied for raw materials as well as in combination tablets. This method may also be applied for the quantification of sofosbuvir and daclatasvir in blood samples of patients taking these two antivirals for hepatitis C treatment. Conclusion: The optimized method was successfully applied for the determination of sofosbuvir and daclatasvir in single run without any interference. Hence, the developed method is quite appropriate for the simultaneous determination of SOF and DCV in solid dosage form as well as in human plasma for clinical research studies. https://ijpihs.pk/index.php/IJPIHS/article/view/118SofosbuvirdaclatasvirRP-HPLCoptimizationvalidation |
| spellingShingle | Syed Hassan Murtaza Ahmed Umer Sohaib Ahmed Tassawer-e-Meran Sonam Anees Najam-ul-Hassan Khan Kishwar Sultana DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR International Journal of Pharmacy & Integrated Health Sciences Sofosbuvir daclatasvir RP-HPLC optimization validation |
| title | DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR |
| title_full | DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR |
| title_fullStr | DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR |
| title_full_unstemmed | DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR |
| title_short | DEVELOPMENT AND VALIDATION OF A NEW RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION AND QUANTIFICATION OF SOFOSBUVIR AND DACLATASVIR |
| title_sort | development and validation of a new rp hplc method for simultaneous determination and quantification of sofosbuvir and daclatasvir |
| topic | Sofosbuvir daclatasvir RP-HPLC optimization validation |
| url | https://ijpihs.pk/index.php/IJPIHS/article/view/118 |
| work_keys_str_mv | AT syedhassanmurtaza developmentandvalidationofanewrphplcmethodforsimultaneousdeterminationandquantificationofsofosbuviranddaclatasvir AT ahmedumersohaibahmed developmentandvalidationofanewrphplcmethodforsimultaneousdeterminationandquantificationofsofosbuviranddaclatasvir AT tassaweremeran developmentandvalidationofanewrphplcmethodforsimultaneousdeterminationandquantificationofsofosbuviranddaclatasvir AT sonamanees developmentandvalidationofanewrphplcmethodforsimultaneousdeterminationandquantificationofsofosbuviranddaclatasvir AT najamulhassankhan developmentandvalidationofanewrphplcmethodforsimultaneousdeterminationandquantificationofsofosbuviranddaclatasvir AT kishwarsultana developmentandvalidationofanewrphplcmethodforsimultaneousdeterminationandquantificationofsofosbuviranddaclatasvir |